Opposing effects of chronic glucagon receptor agonism and antagonism on amino acids, hepatic gene expression, and alpha cells-Reference-Cited by-同舟云学术

Opposing effects of chronic glucagon receptor agonism and antagonism on amino acids, hepatic gene expression, and alpha cells

Published:2022-11 Issue:11 Volume:25 Page:105296
ISSN:2589-0042
Container-title:iScience
language:en
Short-container-title:iScience

Author:

Elmelund Emilie,Galsgaard Katrine D.,Johansen Christian D.,Trammell Samuel A.J.,Bomholt Anna B.,Winther-Sørensen Marie,Hunt Jenna E.,Sørensen Charlotte M.,Kruse Thomas,Lau Jesper F.,Grevengoed Trisha J.,Holst Jens J.,Wewer Albrechtsen Nicolai J.

Publisher

Elsevier BV

Subject

Multidisciplinary

Reference74 articles.

1. MEDI0382, a GLP-1 and glucagon receptor dual agonist, in obese or overweight patients with type 2 diabetes: a randomised, controlled, double-blind, ascending dose and phase 2a study;Ambery;Lancet,2018

2. Differential expression analysis for sequence count data;Anders;Genome Biol.,2010

3. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium;Ashburner;Nat. Genet.,2000

4. Potent inhibitory effects of transplantable rat glucagonomas and insulinomas on the respective endogenous islet cells are associated with pancreatic apoptosis;Blume;J. Clin. Invest.,1995

5. Glucagon increases hepatic mRNA concentrations of ureagenic and gluconeogenic enzymes in early-lactation dairy cows;Bobe;J. Dairy Sci.,2009

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hepatic steatosis and not type 2 diabetes, body mass index, or hepatic fibrosis associates with hyperglucagonemia in individuals with steatotic liver disease;American Journal of Physiology-Gastrointestinal and Liver Physiology;2024-10-01

2. Chronic treatment with glucagon-like peptide-1 and glucagon receptor co-agonist causes weight loss-independent improvements in hepatic steatosis in mice with diet-induced obesity;Biomedicine & Pharmacotherapy;2024-07

3. Glucagon infusion alters the circulating metabolome and urine amino acid excretion in dogs;Journal of Endocrinology;2024-05-30

4. Glucagon resistance and metabolic-associated steatotic liver disease: a review of the evidence;Journal of Endocrinology;2024-04-03

5. Integration of metabolic flux with hepatic glucagon signaling and gene expression profiles in the conscious dog;American Journal of Physiology-Endocrinology and Metabolism;2024-04-01